Skip to Content

COMETRIQ 20 mg hard capsules

Licence status
Authorised:
Active substances
Cabozantinib (s)-malate
Dosage Form
Capsule, hard
Licence number
EU/1/13/890/001
Licence holder
Ipsen Pharma

Licence information

ATC code
L01XE Protein kinase inhibitors, L01XE26 Protein kinase inhibitors
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription. (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued